New Parkinson's injection could replace daily pills
Disease control
Recruiting now
This early-stage study tests a new long-acting injection called HNC364 for Parkinson's disease. It compares how the body processes the injection versus the standard rasagiline tablet (AZILECT). The study involves 30 healthy adults to check safety and how well the drug is absorbed…
Phase: PHASE1 • Sponsor: Guangzhou Henovcom Bioscience Co. Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC